(MedPage Today) — SAN DIEGO — Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring orthopedic care.
One study suggested that semaglutide (Ozempic, Wegovy) boosted the risk of adverse…
Source link : https://www.medpagetoday.com/meetingcoverage/aaos/114670
Author :
Publish date : 2025-03-14 21:21:00
Copyright for syndicated content belongs to the linked Source.
